Crowe J - Search Results

1

Pegylated interferon-α induced hypoferremia is associated with the immediate response to treatment in hepatitis C.

Ryan JD, Altamura S, Devitt E, Mullins S, Lawless MW, Muckenthaler MU, Crowe J. Ryan JD, et al. Among authors: crowe j. Hepatology. 2012 Aug;56(2):492-500. doi: 10.1002/hep.25666. Epub 2012 Jun 11. Hepatology. 2012. PMID: 22334511 Clinical Trial.

2

Early viral and peripheral blood mononuclear cell responses to pegylated interferon and ribavirin treatment: the first 24 h.

Devitt E, Lawless MW, Sadlier D, Browne JA, Walsh C, Crowe J. Devitt E, et al. Among authors: crowe j. Eur J Gastroenterol Hepatol. 2010 Oct;22(10):1211-20. doi: 10.1097/MEG.0b013e32833caf7b. Eur J Gastroenterol Hepatol. 2010. PMID: 20631625

3

Defective bone morphogenic protein signaling underlies hepcidin deficiency in HFE hereditary hemochromatosis.

Ryan JD, Ryan E, Fabre A, Lawless MW, Crowe J. Ryan JD, et al. Among authors: crowe j. Hepatology. 2010 Oct;52(4):1266-73. doi: 10.1002/hep.23814. Hepatology. 2010. PMID: 20658468

4

Early proteomic analysis may allow noninvasive identification of hepatitis C response to treatment with pegylated interferon α-2b and ribavirin.

Devitt EJ, Power KA, Lawless MW, Browne JA, Gaora PO, Gallagher WM, Crowe J. Devitt EJ, et al. Among authors: crowe j. Eur J Gastroenterol Hepatol. 2011 Feb;23(2):177-83. doi: 10.1097/MEG.0b013e3283424e3e. Eur J Gastroenterol Hepatol. 2011. PMID: 21164346 Clinical Trial.

5

Reply: To PMID 22334511.

Ryan JD, Altamura S, Muckenthaler M, Crowe J. Ryan JD, et al. Among authors: crowe j. Hepatology. 2014 Apr;59(4):1648-9. doi: 10.1002/hep.26764. Epub 2014 Feb 14. Hepatology. 2014. PMID: 24122806 No abstract available.

6

GNPAT variant is not associated with severe iron overload in Irish C282Y homozygotes.

Ryan E, Russell J, Ryan JD, Crowe J, Stewart S. Ryan E, et al. Among authors: crowe j. Hepatology. 2016 Jun;63(6):2055-6. doi: 10.1002/hep.28258. Epub 2015 Oct 28. Hepatology. 2016. PMID: 26418756 No abstract available.

7

Correlates of hepcidin and NTBI according to HFE status in patients referred to a liver centre.

Ryan E, Ryan JD, Russell J, Coughlan B, Tjalsma H, Swinkels DW, Stewart S, Crowe JP. Ryan E, et al. Among authors: crowe jp. Acta Haematol. 2015;133(2):155-61. doi: 10.1159/000363490. Epub 2014 Sep 26. Acta Haematol. 2015. PMID: 25277871 Clinical Trial.

8

Hemochromatosis: as a conformational disorder.

Gray SG, Crowe J, Lawless MW. Gray SG, et al. Among authors: crowe j. Int J Biochem Cell Biol. 2009 Nov;41(11):2094-7. doi: 10.1016/j.biocel.2009.04.006. Epub 2009 Apr 16. Int J Biochem Cell Biol. 2009. PMID: 19375516 Review.

9

Hepatitis C management: the challenge of dropout associated with male sex and injection drug use.

Lowry DJ, Ryan JD, Ullah N, Kelleher TB, Crowe J. Lowry DJ, et al. Among authors: crowe j. Eur J Gastroenterol Hepatol. 2011 Jan;23(1):32-40. doi: 10.1097/MEG.0b013e3283414122. Eur J Gastroenterol Hepatol. 2011. PMID: 21048503

10

Ferritin in decompensated cirrhosis: iron or inflammation?

Ryan JD, Chin JL, Crowe J. Ryan JD, et al. Among authors: crowe j. J Hepatol. 2015 Feb;62(2):499-500. doi: 10.1016/j.jhep.2014.08.058. Epub 2014 Nov 7. J Hepatol. 2015. PMID: 25450211 Free article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,247 results

Search Page

Filters